Literature DB >> 28321517

Long-term follow-up study of gastric adenoma; tumor-associated macrophages are associated to carcinoma development in gastric adenoma.

Daiki Taniyama1,2,3, Kiyomi Taniyama4,5,6, Kazuya Kuraoka2,3, Junichi Zaitsu2,3, Akihisa Saito2,3, Hirofumi Nakatsuka7, Naoya Sakamoto1, Kazuhiro Sentani1, Naohide Oue1, Wataru Yasui1.   

Abstract

BACKGROUND: Some gastric adenomas may progress to adenocarcinoma in a short time, but others remain as adenoma for a long time.
METHODS: Among 1138 cases diagnosed as adenoma by biopsy at Kure Medical Association Hospital between 1990 and 2010, 51 adenomas were enrolled. Of these, 28 adenomas (group A) were followed for 60 months or longer with no progression to adenocarcinoma within 60 months, and the other 23 adenomas (group B) were upgraded to carcinoma by consecutive biopsies performed within 1 year after the first biopsy. These adenomas were compared clinicopathologically and immunohistochemically.
RESULTS: Macroscopically, the mean size of group B adenomas was significantly larger than that of group A adenomas (18.6 vs. 9.9 mm) at the first biopsy. The frequency of a depressed area in the adenoma was significantly higher in group B than group A. Microscopically none of group A but 7 (30.4%) of 23 group B adenomas showed severe atypia. Each of a highly proliferative gland measured by Ki-67 labeling, cellular atypical grade, gastric phenotype defined by MUC5AC and MUC6 and CD204-positive tumor-associated macrophage (TAM) was a significant risk factor for adenocarcinoma development in gastric adenoma by univariate analysis. Only moderate or severe atypia of adenoma cells and the TAM number in the stroma of adenomas were independent risk factors by multivariate analysis.
CONCLUSIONS: As independent risk factors, cellular atypia may reconfirm the importance of morphological analysis, and the TAM number may indicate the significance of TAM function in gastric adenoma.

Entities:  

Keywords:  Adenoma-carcinoma sequence; Gastric adenoma; Tumor-associated macrophages

Mesh:

Year:  2017        PMID: 28321517     DOI: 10.1007/s10120-017-0713-x

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  33 in total

1.  MUC gene expression and histogenesis of adenocarcinoma of the stomach.

Authors:  S Tsukashita; R Kushima; M Bamba; H Sugihara; T Hattori
Journal:  Int J Cancer       Date:  2001-10-15       Impact factor: 7.396

2.  Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head.

Authors:  Kiyoshi Yoshikawa; Shuichi Mitsunaga; Taira Kinoshita; Masaru Konishi; Shinichiro Takahashi; Naoto Gotohda; Yuichiro Kato; Masaki Aizawa; Atsushi Ochiai
Journal:  Cancer Sci       Date:  2012-10-04       Impact factor: 6.716

3.  The Vienna classification of gastrointestinal epithelial neoplasia.

Authors:  R J Schlemper; R H Riddell; Y Kato; F Borchard; H S Cooper; S M Dawsey; M F Dixon; C M Fenoglio-Preiser; J F Fléjou; K Geboes; T Hattori; T Hirota; M Itabashi; M Iwafuchi; A Iwashita; Y I Kim; T Kirchner; M Klimpfinger; M Koike; G Y Lauwers; K J Lewin; G Oberhuber; F Offner; A B Price; C A Rubio; M Shimizu; T Shimoda; P Sipponen; E Solcia; M Stolte; H Watanabe; H Yamabe
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

Review 4.  Gastric epithelial dysplasia and adenoma: historical review and histological criteria for grading.

Authors:  N S Goldstein; K J Lewin
Journal:  Hum Pathol       Date:  1997-02       Impact factor: 3.466

5.  Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma.

Authors:  Yoichi Ohtaki; Genichiro Ishii; Kanji Nagai; Satoshi Ashimine; Takeshi Kuwata; Tomoyuki Hishida; Mitsuyo Nishimura; Junji Yoshida; Izumi Takeyoshi; Atsushi Ochiai
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

6.  Long-term follow-up study of gastric adenoma/dysplasia.

Authors:  H Yamada; M Ikegami; T Shimoda; N Takagi; M Maruyama
Journal:  Endoscopy       Date:  2004-05       Impact factor: 10.093

7.  Morphological range of hyperplastic polyps and carcinomas arising in hyperplastic polyps of the stomach.

Authors:  T Hattori
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

8.  Gastric dysplasia. A histological follow-up study.

Authors:  E P Saraga; D Gardiol; J Costa
Journal:  Am J Surg Pathol       Date:  1987-10       Impact factor: 6.394

9.  Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients.

Authors:  Naohide Oue; Kazuhiro Sentani; Tsuyoshi Noguchi; Shinya Ohara; Naoya Sakamoto; Tetsutaro Hayashi; Katsuhiro Anami; Junichi Motoshita; Masanori Ito; Shinji Tanaka; Kazuhiro Yoshida; Wataru Yasui
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

10.  Tyrosine1248-phosphorylated HER2 expression and HER2 gene amplification in female invasive ductal carcinomas.

Authors:  Kiyomi Taniyama; Katsunari Ishida; Tamaki Toda; Junichi Motoshita; Kazuya Kuraoka; Akihisa Saito; Yoichi Tani; Toshinori Uike; Seiichi Teramoto; Masato Koseki
Journal:  Breast Cancer       Date:  2008-02-09       Impact factor: 4.239

View more
  8 in total

1.  Potential Prognostic Value and Mechanism of Stromal-Immune Signature in Tumor Microenvironment for Stomach Adenocarcinoma.

Authors:  Xinying Zhu; Xiaoli Xie; Qingchao Zhao; Lixian Zhang; Changjuan Li; Dongqiang Zhao
Journal:  Biomed Res Int       Date:  2020-06-26       Impact factor: 3.411

Review 2.  Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer.

Authors:  Chunxiao Li; Xiaofei Xu; Shuhua Wei; Ping Jiang; Lixiang Xue; Junjie Wang
Journal:  J Immunother Cancer       Date:  2021-01       Impact factor: 12.469

3.  Sporadic non-ampullary duodenal adenoma with low-grade dysplasia: Natural history and clinical management.

Authors:  Yohei Ikenoyama; Shoichi Yoshimizu; Ken Namikawa; Yoshitaka Tokai; Yusuke Horiuchi; Akiyoshi Ishiyama; Toshiyuki Yoshio; Toshiaki Hirasawa; Junko Fujisaki
Journal:  Endosc Int Open       Date:  2022-03-14

Review 4.  Therapeutic strategies for gastric cancer targeting immune cells: Future directions.

Authors:  Yan Zhao; Yuansong Bai; Meili Shen; Yapeng Li
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

5.  Differences in Somatic Mutation Profiles between Korean Gastric Cancer and Gastric Adenoma Patients.

Authors:  Seung Woo Lee; Taekyu Lee; Hae Jung Sul; Ki Cheol Park; Joonhong Park
Journal:  J Clin Med       Date:  2021-05-10       Impact factor: 4.241

6.  Potential miRNA-target interactions for the screening of gastric carcinoma development in gastric adenoma/dysplasia.

Authors:  Yu Jin Kim; Ki-Chul Hwang; Sang Woo Kim; Yong Chan Lee
Journal:  Int J Med Sci       Date:  2018-03-14       Impact factor: 3.738

7.  CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer.

Authors:  Zhenguo Cheng; Danhua Zhang; Baocheng Gong; Pengliang Wang; Funan Liu
Journal:  Oncotarget       Date:  2017-08-14

8.  Tumor-associated macrophages (TAMs) as biomarkers for gastric cancer: A review.

Authors:  Meri R Räihä; Pauli A Puolakkainen
Journal:  Chronic Dis Transl Med       Date:  2018-09-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.